Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multiplexed gene expression profiling identifies the FGFR4 pathway as a novel biomarker in intrahepatic cholangiocarcinoma

7 Apr 2017

Abstract excerpt

// Changhoon Yoo 1 , Jihoon Kang 1 , Deokhoon Kim 2 , Kyu-Pyo Kim 1 , Baek-Yeol Ryoo 1 , Seung-Mo Hong 3 , Jung Jin Hwang 4 , Seong-Yun Jeong 4 , Shin Hwang 5 , Ki-Hun Kim 5 , Young-Joo Lee 5 , Klaus P. Hoeflich 6 , Oleg Schmidt-Kittler 6 , Stephen Miller 6 , Eun Kyung Choi 4, 7 1 Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea 2 Asan Institute for Life Science,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholangiocarcinoma and Gallbladder Cancer Studies
Share to Fibroblast Growth Factor Research
Share to Pancreatic and Hepatic Oncology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28445152
DOI: 10.18632/oncotarget.16951

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multiplexed gene expression profiling identifies the FGFR4 pathway as a novel biomarker in intrahepatic cholangiocarcinomaPMID 28445152Read ↗

Patient-led functional genomics identifies novel drivers of intrahepatic cholangiocarcinomaSemantic proximity Read ↗

Intrahepatic cholangiocarcinoma with FGFR alterations: A series of Chinese cases with an emphasis on their clinicopathologic and genetic features.Semantic proximity Read ↗

Characterization of EGFR family gene aberrations in cholangiocarcinomaSemantic proximity Read ↗

Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issueSemantic proximity Read ↗

UBA3 is a potential diagnostic marker and regulates the proliferation and migration in intrahepatic cholangiocarcinamaSemantic proximity Read ↗

Targeted genomic profiling revealed a unique clinical phenotype in intrahepatic cholangiocarcinoma with fibroblast growth factor receptor rearrangementSemantic proximity Read ↗

Expression of fibroblast growth factor receptor 2 (FGFR2) in combined hepatocellular-cholangiocarcinoma and intrahepatic cholangiocarcinoma: clinicopathological studySemantic proximity Read ↗

FGFR2 Inhibition in Cholangiocarcinoma.Semantic proximity Read ↗

FGFR Inhibitors: Clinical Activity and Development in the Treatment of Cholangiocarcinoma.Semantic proximity Read ↗

Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma.Semantic proximity Read ↗

Past, present, and future of FGFR inhibitors in cholangiocarcinoma: from biological mechanisms to clinical applications.Semantic proximity Read ↗

Developments in FGFR and IDH inhibitors for cholangiocarcinoma therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.